Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Amerant Bancorp
AMTB
$1.16B
| $932K | ﹤0.01% |
51,137
-10,291
| -17% | -$183K |
|
4352
PUT
Ambarella
AMBA
$3.25B
| $932K | ﹤0.01% |
14,100
-4,900
| -26% | -$260K |
|
4353
Actinium Pharmaceuticals
ATNM
$26.3M
| $929K | ﹤0.01% |
+663,269
| New | +$993K |
|
4354
Ichor Holdings
ICHR
$2.61B
| $927K | ﹤0.01% |
47,219
+26,346
| +126% | +$483K |
|
4355
Harmony Biosciences
HRMY
$2.08B
| $926K | ﹤0.01% |
29,289
-49,203
| -63% | -$1.58M |
|
4356
PUT
Sysco
SYY
$40.6B
| $924K | ﹤0.01% |
12,200
-19,300
| -61% | -$1.4M |
|
4357
Regenxbio
RGNX
$648M
| $919K | ﹤0.01% |
111,949
-220,880
| -66% | -$1.85M |
|
4358
Opko Health
OPK
$993M
| $918K | ﹤0.01% |
695,780
-5,691,131
| -89% | -$7.78M |
|
4359
CALL
Asana
ASAN
$1.83B
| $918K | ﹤0.01% |
68,000
-163,700
| -71% | -$2.57M |
|
4360
OmniAb
OABI
$288M
| $917K | ﹤0.01% |
650,316
+518,645
| +394% | +$868K |
|
4361
FS Bancorp
FSBW
$318M
| $916K | ﹤0.01% |
23,251
+1,898
| +9% | +$73.5K |
|
4362
PUT
NetEase
NTES
$84.4B
| $915K | ﹤0.01% |
6,800
-4,700
| -41% | -$540K |
|
4363
Gevo
GEVO
$372M
| $915K | ﹤0.01% |
693,251
-2,585,010
| -79% | -$3.03M |
|
4364
Stratasys
SSYS
$697M
| $914K | ﹤0.01% |
79,690
+20,604
| +35% | +$209K |
|
4365
TScan Therapeutics
TCRX
$49.4M
| $914K | ﹤0.01% |
630,138
+398,963
| +173% | +$576K |
|
|
NPB
4366
Northpointe Bancshares
NPB
$598M
| $911K | ﹤0.01% |
66,482
-105,795
| -61% | -$1.42M |
|
4367
Burke & Herbert Financial Services Corp
BHRB
$1.47B
| $909K | ﹤0.01% |
15,225
-14,372
| -49% | -$796K |
|
|
AKRO
4368
CALL
DELISTED
Akero Therapeutics
AKRO
| $907K | ﹤0.01% |
17,000
+2,000
| +13% | +$90.9K |
|
4369
PUT
Peabody Energy
BTU
$2.61B
| $905K | ﹤0.01% |
67,400
-117,300
| -64% | -$1.55M |
|
4370
Monarch Casino & Resort
MCRI
$2.19B
| $904K | ﹤0.01% |
10,463
-9,050
| -46% | -$730K |
|
4371
NRC Health Common Stock
NRC
$419M
| $904K | ﹤0.01% |
53,810
+11,770
| +28% | +$159K |
|
4372
Neumora Therapeutics
NMRA
$306M
| $903K | ﹤0.01% |
1,231,392
+513,066
| +71% | +$389K |
|
4373
PUT
Air Products & Chemicals
APD
$66.8B
| $903K | ﹤0.01% |
3,200
-1,400
| -30% | -$383K |
|
4374
CALL
McCormick & Company Non-Voting
MKC
$13.7B
| $902K | ﹤0.01% |
11,900
+600
| +5% | +$45K |
|
4375
CALL
OneMain Financial
OMF
$7.32B
| $901K | ﹤0.01% |
15,800
-3,500
| -18% | -$175K |
|
Similar funds
Millennium Management's Q2 2025 Portfolio in Review
As of Q2 2025, Millennium Management held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Millennium Management added most to Applovin in Q2 2025, an estimated $751M increase.
- Millennium Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Millennium Management fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Millennium Management's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Millennium Management opened 738 new positions and closed 712 in Q2 2025.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.